This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to What Do We Know About Insulin Resistance and Glucose Metabolism in Patients With Schizophrenia Treated With Antipsychotics?

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: I appreciate the comments by Karagianis et al. and Arranz and San on the issue of antipsychotic agents, insulin resistance, and glucose metabolism. The authors touch upon very important topics and limitations to our study, which were addressed in the Discussion section of the article.1 Arranz and San correctly point out that the sample size of our study was small and that olanzapine-treated subjects received the drug for a longer period of time’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 68

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Epidemiology of Treatment-Resistant Depression in the United States

This study used 2 insurance databases to estimate the prevalence of treatment-resistant depression among US patients with...

Read More...